MSD Partners’s Armata Pharmaceuticals ARMP Stock Holding History

MSD Partners’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,072	Closed	-$5K	–	27
2019 Q1	$5K	Hold	1,072	–	–	﹤0.01%	26
2018 Q4	$3K	Hold	1,072	–	–	﹤0.01%	27
2018 Q3	$15K	Hold	1,072	–	–	﹤0.01%	37
2018 Q2	$17K	Hold	1,072	–	–	﹤0.01%	41
2018 Q1	$16K	Hold	1,072	–	–	﹤0.01%	32
2017 Q4	$15K	Hold	1,072	–	–	﹤0.01%	24
2017 Q3	$14K	Hold	1,072	–	–	﹤0.01%	34
2017 Q2	$12K	Hold	1,072	–	–	﹤0.01%	36
2017 Q1	$65K	Hold	1,072	–	–	﹤0.01%	34
2016 Q4	$66K	Hold	1,072	–	–	﹤0.01%	33
2016 Q3	$228K	Hold	1,072	–	–	0.02%	31
2016 Q2	$233K	Hold	1,072	–	–	0.02%	53
2016 Q1	$591K	Sell	1,072 -377	-26%	-$193K	0.03%	60
2015 Q4	$808K	Sell	1,449 -505	-26%	-$387K	0.03%	49
2015 Q3	$1.08M	Buy	+1,954	New	+$1.79M	0.04%	56

Other funds holding ARMP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

GWM

Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MSD Partners's ARMP Position: Q2 2019 in Review

MSD Partners sold out of Armata Pharmaceuticals (ARMP) in Q2 2019, closing a stake of 1,072 shares — an estimated $5K sold.

MSD Partners first reported a position in ARMP in Q3 2015 and held it in 15 quarters. The position peaked at $1.08M in Q3 2015. 12 funds tracked by Wall St. Rank hold ARMP as of Q2 2019.

MSD Partners reported no remaining Armata Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
MSD Partners sold 1,072 Armata Pharmaceuticals shares in Q2 2019, an estimated $5K.
MSD Partners first reported a position in Armata Pharmaceuticals in Q3 2015 and held it in 15 quarters.
MSD Partners's Armata Pharmaceuticals position peaked at $1.08M in Q3 2015.
12 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2019.

Based on MSD Partners's 13F filing for Q2 2019, filed 14 Aug 2019.